CDKN2A and neoplasm: The growth of tumor cells is inhibited both in vivo and in vitro when p16INK4a gene is transferred into lung cancer cells, glioma cells and gastric cancer cells without p16INK4a expression by transgenic technology, suggesting that the expressed product has tumor therapeutic effect [48–50].